Prednisolone 5 mg Kela 5 mg Tablet
Prednisolone 5 mg Kela 5 mg Tablet
Authorised
- Prednisolone
Product identification
Medicine name:
Prednisolone 5 mg Kela 5 mg Tablet
Active substance:
- Prednisolone
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Prednisolone5.00/milligram(s)200000.00milligram(s)
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD07BA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Prednisolone 5 mg Kela 100 Tablets in Blister
- Prednisolone 5 mg Kela 50 Tablets in Blister
- Prednisolone 5 mg Kela 30 Tablets in Blister
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KELA Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
- KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V199516
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
